Charter Finl Corp (CHFN) 13.15 $CHFN Charter Financial

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Charter Finl Corp (CHFN) 13.15 $CHFN

Charter Financial Announces Third Quarter Fiscal 2016 Earnings of $1.3 Million
GlobeNewswire - Fri Jul 29, 7:00AM CDT
-- Completed acquisition of CBS Financial Corporation
CHFN: 13.15 (-0.15)

Charter posts 2Q profit
Automated Insights - Thu Apr 28, 2:49PM CDT
WEST POINT, Ga. (AP) _ Charter Financial Corp. (CHFN) on Thursday reported fiscal second-quarter profit of $2.1 million.
CHFN: 13.15 (-0.15)

Charter Financial Announces Second Quarter Fiscal 2016 Earnings of $2.1 Million
GlobeNewswire - Thu Apr 28, 5:30AM CDT
-- Tangible book value per share of $12.89 at March 31, 2016, up $0.50 year over year
CHFN: 13.15 (-0.15)

72.3% Return Seen to Date on SmarTrend Charter Financial Call (CHFN)
Comtex SmarTrend(R) - Wed Apr 27, 12:55PM CDT
SmarTrend identified an Uptrend for Charter Financial (NASDAQ:CHFN) on June 27th, 2012 at $7.75. In approximately 47 months, Charter Financial has returned 72.26% as of today's recent price of $13.35.
CHFN: 13.15 (-0.15)

Charter Financial Declares Regular Quarterly Cash Dividend
GlobeNewswire - Tue Apr 26, 12:46PM CDT
Charter Financial Corporation (NASDAQ:CHFN) today announced that its board of directors has declared a regular quarterly cash dividend of $0.05 per share. The dividend is payable on May 25, 2016, to stockholders of record as of May 11, 2016.
CHFN: 13.15 (-0.15)

Charter Financial Shares Up 73.8% Since SmarTrend's Buy Recommendation (CHFN)
Comtex SmarTrend(R) - Wed Apr 20, 12:30AM CDT
SmarTrend identified an Uptrend for Charter Financial (NASDAQ:CHFN) on June 27th, 2012 at $7.75. In approximately 46 months, Charter Financial has returned 73.81% as of today's recent price of $13.47.
CHFN: 13.15 (-0.15)

Charter Financial Completes Merger With CBS Financial Corporation
GlobeNewswire - Fri Apr 15, 5:00PM CDT
Charter Financial Corporation (NASDAQ:CHFN) announced today the completion of its merger (the "Merger" with Smyrna, Georgia-based CBS Financial Corporation ("CBS" effective April 15, 2016, pursuant to the previously announced definitive Agreement and Plan of Merger (the "Merger Agreement" between Charter Financial Corporation ("Company" and CBS, dated as of December 3, 2015. Additionally, Community Bank of the South, a wholly-owned subsidiary of CBS which operated four branches in the Atlanta metropolitan area, has merged with and into CharterBank, a wholly-owned subsidiary of the Company. The combined Company has approximately $1.4 billion of total assets with 19 banking offices in west-central Georgia, east-central Alabama, and the Florida Gulf Coast.
CHFN: 13.15 (-0.15)

ServisFirst Bancshares (SFBS) in Focus: Stock Rises 7.5%
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 7:45AM CDT
ServisFirst Bancshares, Inc. (SFBS) was a big mover last session, as the company saw its shares rise over 7% on the day.
CHFN: 13.15 (-0.15), SFBS: 52.41 (+0.01)

Charter Financial Has Returned 73.4% Since SmarTrend Recommendation (CHFN)
Comtex SmarTrend(R) - Tue Mar 29, 12:15AM CDT
SmarTrend identified an Uptrend for Charter Financial (NASDAQ:CHFN) on June 27th, 2012 at $7.75. In approximately 46 months, Charter Financial has returned 73.42% as of today's recent price of $13.44.
CHFN: 13.15 (-0.15)

Shares of CHFN Up 75.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Feb 02, 5:31PM CST
SmarTrend identified an Uptrend for Charter Financial (NASDAQ:CHFN) on June 27th, 2012 at $7.75. In approximately 44 months, Charter Financial has returned 75.48% as of today's recent price of $13.60.
CHFN: 13.15 (-0.15)

New Strong Buy Stocks for January 29th
Zacks Equity Research - Zacks Investment Research - Fri Jan 29, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
CHFN: 13.15 (-0.15), BANC: 22.32 (+0.10), LPG: 5.33 (-0.29), BBCN: 15.37 (-0.21), BABA: 97.19 (+1.19)

Charter Financial Announces First Quarter Fiscal 2016 Earnings of $4.6 Million
GlobeNewswire - Thu Jan 28, 3:13PM CST
-- Tangible book value per share of $12.73 at December 31, 2015, up $0.44 year over year
CHFN: 13.15 (-0.15)

Charter Financial Up 70.1% Since SmarTrend Uptrend Call (CHFN)
Comtex SmarTrend(R) - Tue Jan 26, 2:25PM CST
SmarTrend identified an Uptrend for Charter Financial (NASDAQ:CHFN) on June 27th, 2012 at $7.75. In approximately 44 months, Charter Financial has returned 70.06% as of today's recent price of $13.18.
CHFN: 13.15 (-0.15)

Charter Financial Up 63.0% Since SmarTrend Uptrend Call (CHFN)
Comtex SmarTrend(R) - Tue Jan 19, 10:48AM CST
SmarTrend identified an Uptrend for Charter Financial (NASDAQ:CHFN) on June 27th, 2012 at $7.75. In approximately 43 months, Charter Financial has returned 62.97% as of today's recent price of $12.63.
CHFN: 13.15 (-0.15)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 60

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 24

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 139

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 11

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 150

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 254

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 94

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 31

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

BitGo Faces Securities Fraud Suit Amid Investor Losses

Updated Category News Views 69

BitGo's Legal Woes: A Deep Dive into the Allegations A lawsuit can shake up a company's foundations, and BitGo Holdings, Inc. (NYSE: BTGO) is feeling the heat right now. The focus of this busy investor morning isn’t some penny stock drama; we're talking about players in the digital asset game accused of pulling the wool over investors' eyes. Slap on those reading...

Continue Reading
Investors Alert: Deadline Approaches in Match Group Lawsuit

Updated Category News Views 141

Important Deadline Approaching for Match Group Investors Recently, there has been a notable reminder for investors concerning a class action lawsuit involving Match Group, Inc. (NASDAQ: MTCH). The law firm Glancy Prongay & Murray LLP has highlighted that all individuals who purchased shares in Match Group during the specified period should be aware of the upcoming...

Continue Reading
Leadership Transition at Coloplast A/S: New Era Begins

Updated Category News Views 937

Coloplast A/S Announces Leadership Change In a significant shift for Coloplast A/S, CEO Kristian Villumsen has officially stepped down. Today marks the start of a new chapter as the Board of Directors mobilizes Lars Rasmussen to serve as interim CEO while the search for a permanent replacement is conducted. Strategic Shift for the Future This change comes at an opportune...

Continue Reading
Johnson & Johnson's Strong Q3 Results Amid Market Declines

Updated Category News Views 109

Market Overview On a day marked by declining values, U.S. stocks experienced a noticeable downturn. The Nasdaq Composite index saw a drop of around 150 points, indicating a challenging market environment. As trading progressed, the Dow Jones Industrial Average slipped slightly, and the S&P 500 also followed suit, showing varied performance across sectors. Sector...

Continue Reading
Moroccanoil Expands Product Line at Ulta Beauty Nationwide

Updated Category News Views 204

Moroccanoil Expands Product Line at Ulta Beauty Nationwide Moroccanoil is thrilled to announce an exciting partnership with Ulta Beauty, the premier beauty retailer in the nation. This significant expansion reaffirms Moroccanoil's commitment to delivering high-quality beauty products to a wider audience while honoring its legacy rooted in the salon community. Launching at...

Continue Reading